Evidence map›Paper›PMID 36624035›Full record

Observational studyEnfermedades infecciosas y microbiologia clinica (English ed.)2023

Use of antibiotics in Paediatric Primary Health Care before and during the COVID-19 pandemic.

David Pérez Solís, Constanza Gómez de Oña, María Luisa Nicieza García, Patricio Suárez Gil, Pablo Pérez Solís, Belén Suárez Mier, Valeria Rolle Sóñora

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Enfermedades infecciosas y microbiologia clinica (English ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

David Pérez SolísServicio de Pediatría, Hospital Universitario San Agustín, Avilés, Spain. Electronic address: david@perezsolis.e.
Constanza Gómez de OñaServicio de Farmacia de Atención Primaria, Área Sanitaria V del Servicio de Salud del Principado de Asturias, Gijón, Asturias, Spain.
María Luisa Nicieza GarcíaServicio de Farmacia, Dirección General de Política y Planificación Sanitarias, Consejería de Salud, Asturias, Spain.
Patricio Suárez GilPlataforma de Bioestadística y Epidemiología, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Spain.
Pablo Pérez SolísMedicina Familiar y Comunitaria, Centro de Salud Laviada, Gijón, Asturias, Spain.
Belén Suárez MierEstrategia de Seguridad del Paciente, Dirección General de Calidad, Transformación y Gestión del Conocimiento, Consejería de Salud, Asturias, Spain.
Valeria Rolle SóñoraPlataforma de Bioestadística y Epidemiología, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias · ESConsejería de Educación de la Junta de Castilla y León · ESGobierno del Principado de Asturias · ESHospital Universitario San Agustín · ESSociedad Andaluza de Medicina Familiar y Comunitaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionConsumption of antibiotics is high in Spain, primarily in children. Excessive use of then contributes to the development of antimicrobial resistance. The aim of our study is to analyse the evolution of antibiotic consumption at the Primary Health Care in the paediatric population of Asturias, Spain, from 2014 to 2021, and to evaluate the impact of COVID-19 pandemic on it.

methodsRetrospective and observational study using data about antibacterial agents for systemic use dispensed for official prescriptions to children under 14 years in Primary Care. Antibiotic consumption is expressed as defined daily dose (DDD) per 1000 inhabitants per day (DID).

resultsThe antibiotic consumption rate dropped from 13.9 DID in 2014 to 4.0 in 2021 (β=-1,42, p=0,002), with and inflection point in 2019. From 2019 to 2020 antibiotic use dropped by 47.1%. Antibiotic consumption remained very low from April 2020 to September 2021, and then moderately increased from October 2021. Prevalence of antibiotic use dropped from 39.9% in 2014 to 17.5% in 2021 (β=-3,64, p=0,006). Relative consumption of amoxicillin/clavulanic acid decreased, while those of amoxiciline and third-generation cephalosporins increased.

conclusionsPaediatric antibiotic consumption collapsed in Asturias in 2020, coinciding with COVID-19 pandemic. Monitoring of antimicrobial usage indicators will allow to check if these changes are sustained over time.

Indexed as

Anti-Bacterial AgentsCOVID-19ChildHumansPandemicsPrimary Health CareRetrospective StudiesAnti-Bacterial AgentsAnti-bacterial agentsAntibacterianosAtención primaria de saludCOVID-19PaediatricsPediatríaPrescription drug monitoring programsPrimary Health CareProgramas de monitoreo de medicamentos recetados

Identifiers

PMID36624035
PMCPMC9792423
OpenAlexW4313256751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.